Kobayashi K, Sugimoto T, Makino H, Kumagai M, Unoura M, Tanaka N, Kato Y, Hattori N
Hepatology. 1985 Nov-Dec;5(6):1100-5. doi: 10.1002/hep.1840050607.
The value of various screening methods in the detection of early hepatocellular carcinoma was investigated in 95 patients with cirrhosis. Infusion hepatic angiography and computed tomography with angiography were performed yearly, ultrasound every 3 months, and determination of serum alpha-fetoprotein levels every 2 months. "Space-occupying lesions" suspicious for hepatocellular carcinoma were found in 13 of the 95 cases (13.7%). Detection rates of "space-occupying lesions" were 77% for infusion hepatic angiography, 77% for computed tomography with angiography and 54% for ultrasonography, respectively. In 8 of the 13 cases, "space-occupying lesions" were subsequently confirmed as hepatocellular carcinoma by operative findings or clinical course. Serum alpha-fetoprotein levels were negative in 3 of the 8 hepatocellular carcinoma-confirmed cases, and 3 of the remaining 5 cases demonstrated levels above 400 ng per ml at the time of diagnosis. A radical resection of hepatocellular carcinoma was successfully performed in two cases. Although it was difficult to differentiate hepatocellular carcinoma from other lesions in the case of "space-occupying lesions" smaller than 2 cm in diameter, the results suggest that regularly scheduled screening may be useful to detect early hepatocellular carcinoma.
对95例肝硬化患者研究了各种筛查方法在早期肝细胞癌检测中的价值。每年进行肝灌注血管造影和血管造影计算机断层扫描,每3个月进行超声检查,每2个月测定血清甲胎蛋白水平。95例中有13例(13.7%)发现可疑肝细胞癌的“占位性病变”。肝灌注血管造影、血管造影计算机断层扫描和超声检查对“占位性病变”的检出率分别为77%、77%和54%。13例中有8例“占位性病变”随后经手术所见或临床病程证实为肝细胞癌。8例确诊为肝细胞癌的病例中有3例血清甲胎蛋白水平为阴性,其余5例中有3例在诊断时甲胎蛋白水平高于400 ng/ml。2例成功进行了肝细胞癌根治性切除。虽然直径小于2 cm的“占位性病变”难以将肝细胞癌与其他病变区分开来,但结果表明定期筛查可能有助于早期肝细胞癌的检测。